⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,823.50
−0.19%
FTSE ADX
9,790.47
−0.40%
TASI
9,952.06
−1.69%
QE Index
8,658.85
+0.70%
S&P 500
7,712.57
+0.28%
Nasdaq 100
29,490.28
−0.13%
Nifty 50
22,704.40
−0.81%
Sensex
73,360.48
−0.67%
KSE-100
165,671.54
+0.31%
DFM:EMIRATESNBD
AED 31.60
+0.06%
ADX:IHC
AED 353.80
−0.79%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.54
−0.06%
NAS:NVDA
$216.47
−0.29%
NYSE:TSM
$425.08
+1.16%
NSE:RELIANCE
₹1,209.60
+0.63%
KAR:OGDC
Rs 300.48
+0.16%
Gold
$4,114.39
−0.27%
Brent
$110.16
+0.98%
BTC
$82,671.58
−0.33%
ETH
$2,438.72
−0.33%
DFM General
5,823.50
−0.19%
FTSE ADX
9,790.47
−0.40%
TASI
9,952.06
−1.69%
QE Index
8,658.85
+0.70%
S&P 500
7,712.57
+0.28%
Nasdaq 100
29,490.28
−0.13%
Nifty 50
22,704.40
−0.81%
Sensex
73,360.48
−0.67%
KSE-100
165,671.54
+0.31%
DFM:EMIRATESNBD
AED 31.60
+0.06%
ADX:IHC
AED 353.80
−0.79%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.54
−0.06%
NAS:NVDA
$216.47
−0.29%
NYSE:TSM
$425.08
+1.16%
NSE:RELIANCE
₹1,209.60
+0.63%
KAR:OGDC
Rs 300.48
+0.16%
Gold
$4,114.39
−0.27%
Brent
$110.16
+0.98%
BTC
$82,671.58
−0.33%
ETH
$2,438.72
−0.33%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Open
🇸🇦
Saudi Arabia
Tadawul · TASI
Open
🇶🇦
Qatar
QSE · QE General
Open
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Closed
🇮🇳
India
NSE · BSE · Nifty 50
Open
🇵🇰
Pakistan
PSX · KSE-100
Open
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
ARS Pharmaceuticals Inc · News · TradingHolo
Markets
›
United States
› NAS
› SPRY
A
ARS Pharmaceuticals Inc
NAS:SPRY
Healthcare
CBOEFTSE:MRUT
NASDAQ:NBI
$4.02
−1.23%
At close
At close · Sat 17 Oct · ≈
AED 14.76
· Market cap
$399.78M
· Next earnings
Mon 9 Nov
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
SPRY news
Headlines tagged to this company
NE
ROSEN, LEADING INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
Newsfile Corp · 67 d ago
GL
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – SPRY
GlobeNewsWire · 67 d ago
NE
Kaplan Fox Reminds ARS Pharmaceuticals Inc. (SPRY) Investors Seeking Recovery of the Lead Plaintiff Deadline on October 5, 2026
Newsfile Corp · 68 d ago
NE
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
Newsfile Corp · 68 d ago
GL
The Gross Law Firm Reminds ARS Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 5, 2026 - SPRY
GlobeNewsWire · 68 d ago
MA
ARS Pharmaceuticals Q2 Earnings Call Highlights
MarketBeat · 69 d ago
ZA
ARS Pharmaceuticals, Inc. (SPRY) Reports Q2 Loss, Tops Revenue Estimates
Zacks Investment Research · 69 d ago
GL
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPRY
GlobeNewsWire · 69 d ago
GL
ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results
GlobeNewsWire · 69 d ago
NE
Did You Lose Money Investing in ARS Pharmaceuticals Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against SPRY
Newsfile Corp · 69 d ago
PR
SPRY Deadline Alert: SueWallSt Reminds ARS Pharmaceuticals Inc. (SPRY) Investors of Securities Class Action Deadline on October 5, 2026
PRNewsWire · 69 d ago
GL
Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewsWire · 69 d ago
PR
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - SPRY
PRNewsWire · 69 d ago
NE
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of ARS Pharmaceuticals, Inc. (SPRY)
Newsfile Corp · 69 d ago
NE
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
Newsfile Corp · 70 d ago
NE
Kaplan Fox Encourages Investors of ARS Pharmaceuticals Inc. (SPRY) Who Suffered Losses to Contact the Firm Before October 5, 2026
Newsfile Corp · 70 d ago
NE
SPRY CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
Newsfile Corp · 70 d ago
PR
SPRY UPCOMING DEADLINE: Levi & Korsinsky Alerts ARS Pharmaceuticals Inc. Stockholders of Securities Class Action - Contact the Firm
PRNewsWire · 70 d ago
GL
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – SPRY
GlobeNewsWire · 71 d ago
PR
SPRY Investors with Losses in Excess of $100K Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit
PRNewsWire · 71 d ago
← Previous
More news →